NASDAQ:LNSR

LENSAR - LNSR Stock Forecast, Price & News

$2.33

-0.02 (-0.85%)

(As of 03/21/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.20
▼
$2.47
50-Day Range: $2.33
▼
$3.27
52-Week Range: $2.15
▼
$8.80

Volume: 21,352 shs
Average Volume: 21,582 shs
Market Capitalization: $25.86 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.00

Institutional Ownership

LENSAR MarketRank™ Forecast

Analyst Rating: N/A
0.00 Rating Score
Upside/Downside: 500.9% Upside
$14.00 Price Target
Short Interest: Healthy
0.42% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.14
Based on 9 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

844th out of 983 stocks

Surgical & Medical Instruments Industry

84th out of 100 stocks

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $14.00, LENSAR has a forecasted upside of 500.9% from its current price of $2.33.
Amount of Analyst Coverage
LENSAR has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
0.42% of the float of LENSAR has been sold short.
Short Interest Ratio / Days to Cover
LENSAR has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in LENSAR has recently decreased by 3.37%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
LENSAR does not currently pay a dividend.
Dividend Growth
LENSAR does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LNSR.

1.7

News and Social Media Coverage

News Sentiment
LENSAR has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.34 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 9 news articles for LENSAR this week, compared to 0 articles on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LENSAR insiders have not sold or bought any company stock.
Percentage Held by Insiders
19.00% of the stock of LENSAR is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
54.43% of the stock of LENSAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of LENSAR is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of LENSAR is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
LENSAR has a P/B Ratio of 0.61. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About LENSAR (NASDAQ:LNSR) Stock

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

LNSR Stock News Headlines

March 21, 2023 | finance.yahoo.com

The Consensus EPS Estimates For LENSAR, Inc. (NASDAQ:LNSR) Just Fell A Lot

March 20, 2023 | finance.yahoo.com

LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript

March 21, 2023 | Weiss Ratings (Ad)

Bank Accounts: Frozen!

In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!

March 18, 2023 | seekingalpha.com

LENSAR, Inc. (LNSR) Q4 2022 Earnings Call Transcript

March 18, 2023 | markets.businessinsider.com

LENSAR (LNSR) Gets a Buy from BTIG

March 16, 2023 | msn.com

LENSAR GAAP EPS of -$0.24 beats by $0.01, revenue of $10.2M beats by $0.2M

March 16, 2023 | finance.yahoo.com

LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

March 15, 2023 | benzinga.com

A Preview Of LENSAR's Earnings

March 21, 2023 | Weiss Ratings (Ad)

Bank Accounts: Frozen!

March 15, 2023 | americanbankingnews.com

LENSAR (LNSR) Set to Announce Quarterly Earnings on Thursday

March 9, 2023 | finance.yahoo.com

LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

March 7, 2023 | finance.yahoo.com

Is LENSAR (NASDAQ:LNSR) In A Good Position To Invest In Growth?

February 16, 2023 | seekingalpha.com

Lensar reports Q4 revenue $10.2M, consensus $10M

February 16, 2023 | nasdaq.com

Silver Point Capital Now Owns 4.40% of LENSAR (LNSR)

February 14, 2023 | finance.yahoo.com

LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

December 13, 2022 | msn.com

LENSAR Earnings Perspective: Return On Capital Employed

November 12, 2022 | seekingalpha.com

LENSAR, Inc. (LNSR) Q3 2022 Earnings Call Transcript

November 9, 2022 | finance.yahoo.com

LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update

November 2, 2022 | finance.yahoo.com

LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

September 28, 2022 | ca.finance.yahoo.com

We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely

September 9, 2022 | finanznachrichten.de

LENSAR, Inc.: LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU

September 8, 2022 | finance.yahoo.com

LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

September 3, 2022 | nasdaq.com

The past year for LENSAR (NASDAQ:LNSR) investors has not been profitable

August 16, 2022 | finance.yahoo.com

First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System

August 1, 2022 | finance.yahoo.com

LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022

June 13, 2022 | finance.yahoo.com

Why Lensar Shares Are Trading Higher Today

June 13, 2022 | seekingalpha.com

LENSAR stock jumps premarket as FDA clears ALLY adaptive cataract treatment system

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

LNSR Company Calendar

Last Earnings: 11/08/2021
Today: 3/21/2023
Next Earnings (Estimated): 5/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:LNSR
CUSIP: N/A
CIK: 1320350
Web: www.lensar.com
Phone: 888-536-7271
Fax: N/A
Employees: 110
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $14.00
High Stock Price Forecast: $14.00
Low Stock Price Forecast: $14.00
Forecasted Upside/Downside: +500.9%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.97)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-19,910,000.00
Net Margins: -56.32%
Pretax Margin: -56.32%
Return on Equity: -44.43%
Return on Assets: -34.69%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.95
Quick Ratio: 1.92

Sales & Book Value

Annual Sales: $35.36 million
Price / Sales: 0.73
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.81 per share
Price / Book: 0.61

Miscellaneous

Outstanding Shares: 11,100,000
Free Float: 8,993,000
Market Cap: $25.86 million
Optionable: Not Optionable
Beta: -0.24

Key Executives

Mr. Nicholas T. Curtis (Age 66)
CEO & Director
Comp: $888.59k

Mr. Thomas R. Staab II (Age 54)
CPA, CFO & Sec.
Comp: $556.51k

Mr. Alan B. Connaughton (Age 50)
Chief Operating Officer
Comp: $594.93k

Ms. Kendra W. Wong (Age 42)
Principal Accounting Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LNSR Stock - Frequently Asked Questions

What is LENSAR's stock price forecast for 2023?: 0 Wall Street analysts have issued 12-month price objectives for LENSAR's shares. Their LNSR share price forecasts range from $14.00 to $14.00. On average, they expect the company's stock price to reach $14.00 in the next year. This suggests a possible upside of 500.9% from the stock's current price.
View analysts price targets for LNSR or view top-rated stocks among Wall Street analysts.
How have LNSR shares performed in 2023?: LENSAR's stock was trading at $2.96 at the beginning of the year. Since then, LNSR stock has decreased by 21.3% and is now trading at $2.33.
View the best growth stocks for 2023 here.
When is LENSAR's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our LNSR earnings forecast.
How were LENSAR's earnings last quarter?: LENSAR, Inc. (NASDAQ:LNSR) issued its quarterly earnings results on Monday, November, 8th. The company reported ($0.65) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.06. The business had revenue of $8.27 million for the quarter, compared to analyst estimates of $7.67 million. LENSAR had a negative trailing twelve-month return on equity of 44.43% and a negative net margin of 56.32%. During the same quarter last year, the company posted ($0.64) earnings per share.
What guidance has LENSAR issued on next quarter's earnings?: LENSAR issued an update on its fourth quarter 2022 earnings guidance on Tuesday, February, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $10.20 million-$10.20 million, compared to the consensus revenue estimate of $10.00 million.
What is LENSAR's stock symbol?: LENSAR trades on the NASDAQ under the ticker symbol "LNSR."

Who are LENSAR's major shareholders?: LENSAR's stock is owned by many different retail and institutional investors. Top institutional investors include North Run Capital LP (9.95%), Silver Point Capital L.P. (4.36%), Renaissance Technologies LLC (2.88%), Millennium Management LLC (0.64%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gary M Winer and Thomas R Staab II.
View institutional ownership trends.
How do I buy shares of LENSAR?: Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LENSAR's stock price today?: One share of LNSR stock can currently be purchased for approximately $2.33.
How much money does LENSAR make?: LENSAR (NASDAQ:LNSR) has a market capitalization of $25.86 million and generates $35.36 million in revenue each year. The company earns $-19,910,000.00 in net income (profit) each year or ($1.97) on an earnings per share basis.
How many employees does LENSAR have?: The company employs 110 workers across the globe.
How can I contact LENSAR?: The official website for the company is www.lensar.com. The company can be reached via phone at 888-536-7271 or via email at ir.contact@lensar.com.

This page (NASDAQ:LNSR) was last updated on 3/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

LENSAR - LNSR Stock Forecast, Price & News

LENSAR MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About LENSAR (NASDAQ:LNSR) Stock

LNSR Stock News Headlines

LNSR Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

LNSR Stock - Frequently Asked Questions

Overall MarketRank^™